Leveraged Buyout (LBO): How Private Equity Actually Buys Companies
An LBO uses equity + significant debt to acquire a company. Here's the capital structure, return drivers, and why LBO math defines PE returns.
Private Equity & Growth Capital in Venture Markets
Private equity and venture capital increasingly overlap at the growth stage, with crossover funds, secondary buyers, and PE firms competing for mature startups. Our coverage explores how late-stage capital shapes valuations, exits, and founder outcomes.
PE & VC Intersection
- Growth equity: Minority growth rounds and crossover participation
- Secondary markets: Liquidity for employees, founders, and early investors
- Buyout dynamics: When PE acquires venture-backed companies
- Fund scale: Mega-funds and their impact on deal competition
Explore private equity and growth capital articles below.
Related Articles (15 articles)
-
-
NYC Is the Global Capital of Private Equity: Blackstone, KKR, Apollo, Carlyle, Warburg
NYC hosts the world's largest PE firms. Blackstone alone manages $1T+; KKR, Apollo, Carlyle, Warburg, General Atlantic add trillions more. Here's the ecosystem.
-
Roll-Up Strategy in Private Equity: How M&A Platforms Build Scale
A roll-up is a PE strategy of acquiring and integrating many small companies into a larger platform. Here's how it actually works and when it beats organic growth.
-
Growth Equity: The Middle Layer Between VC and Buyout, Explained
Growth equity backs mature, revenue-generating companies with minority stakes and lower risk than VC. Here's who the top firms are and when to consider them.
-
Private Equity and Venture Capital Firms: How to Choose in 2026
Private equity and venture capital firms solve different capital problems: PE buys control of mature companies, while VC funds early-stage growth. Compare stage, ownership, leverage, returns, and who to pitch.
-
0100 Europe 2026: The Private Markets Event Where LP Checks Actually Get Discussed
The 0100 Europe gathering on April 21–23 remains one of Europe's most pragmatic venues for GP-LP relationships and private markets deal talk.